ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Ultrasound-Responsive Piezoelectric Fibrous Membrane Promotes Neurological Recovery After TBI by Modulating Microglial Polarization via Restoring Mitochondrial Dynamic Homeostasis.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Mitochondrial dysfunction is a core pathological mechanism underlying secondary injury following traumatic brain injury, with the resulting oxidative stress and inflammatory cascade being key contributors to neurological deficits and poor clinical outcomes. This study developed an ultrasound-responsive piezoelectric fibrous membrane that, under low-intensity pulsed ultrasound (LIPUS) stimulation, generates controllable piezoelectric signals directly at the injury site to precisely regulate mitochondrial function in microglia. This regulation effectively restores mitochondrial dynamics homeostasis and enhances mitochondrial membrane potential (ΔΨm) stability, significantly suppressing the abnormal generation of mitochondrial superoxide and cellular reactive oxygen species (ROS). It promotes the polarization of microglia toward a neuroprotective M2 phenotype, reduces the expression of pro-inflammatory cytokines TNF-α, IL-1β, and IL-6, and enhances the activity of the antioxidant enzyme superoxide dismutase (SOD). In a TBI animal model, this therapeutic strategy markedly alleviated pathological brain damage, improved neuronal survival, ameliorated neurological deficits and spatial memory impairment, and facilitated the polarization of microglia toward an anti-inflammatory (M2) phenotype in the injured area. This study provides a novel strategy for TBI treatment by targeting mitochondrial function regulation, offering potential to overcome the therapeutic challenges in neuroimmunometabolic modulation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.